Churchill Management Corp Regeneron Pharmaceuticals, Inc. Transaction History

Churchill Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$544.75 - $658.21 $1.28 Million - $1.54 Million	-2,346 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$493.32 - $643.92 $1.16 Million - $1.51 Million	2,346 New	2,346 $1.46 Million
Q2 2019 Jul 10, 2019	SELL	$299.6 - $414.82 $1.06 Million - $1.47 Million	-3,543 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$372.08 - $439.57 $589,374 - $696,278	1,584 Added 80.86%	3,543 $1.46 Million
Q4 2018 Jan 15, 2019	BUY	$335.82 - $403.04 $657,871 - $789,555	1,959 New	1,959 $732,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

Stay updated on Churchill Management Corp with notifications on news.